Edition:
India

Insider Trading: Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

116.00USD
30 Mar 2020
Change (% chg)

$2.59 (+2.28%)
Prev Close
$113.41
Open
$113.55
Day's High
$117.38
Day's Low
$113.55
Volume
76,531
Avg. Vol
52,836
52-wk High
$145.59
52-wk Low
$90.06

All Insider Trades

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 189
Total Shares Held: 48,531,789
3 Mo. Net Change: 365,334
# New Positions: 35
# Closed Positions: 18
# Increased Positions: 97
# Reduced Positions: 70
# Net Buyers: 27

Officers & Directors

Name Age Since Current Position

Michael Jensen

47 2013 Chairman of the Board, Senior Vice President, Chief Legal Officer

Jan Moeller Mikkelsen

59 2007 President, Chief Executive Officer, Board Member, Executive Director

Scott Smith

45 2016 Chief Financial Officer, Senior Vice President

Lotte Soenderbjerg

57 2007 Senior Vice President, Chief Administrative Officer

Flemming Jensen

58 2015 Senior Vice President - Product Supply

Thomas Larson

57 2018 Senior Vice President, Chief Commercial Officer

Jonathan Leff

61 2016 Senior Vice President, Chief Medical Officer

Jens Okkels

58 2019 Senior Vice President - Product Development

Juha Punnonen

2018 Senior Vice President - Head of Oncology

Kennett Sprogoee

40 2016 Senior Vice President - Product Innovation and Research

Peter Rasmussen

50 2016 Principal Accounting Officer, Vice President - Finance

Lisa Bright

51 2017 Independent Director

Albert Cha

46 2014 Independent Director

James Healy

53 2014 Independent Director

Lars Holtug

60 2018 Independent Director

Birgitte Volck

56 2016 Independent Director